期刊文献+

围绝经期、绝经期妇女应用结合雌激素治疗 的疗效观察与血脂分析 被引量:2

EFFECT OF CONJUGATED ESTROGEN ON PERIMENOPAUSE SYNDROME AND SERUM LIPOPROTEIN IN PERIMENOPAUSAL AND POSTMENOPAUSAL WOMEN
暂未订购
导出
摘要 目的探讨结合雌激素对围绝经期、绝经期妇女围绝经期症状的疗效及对血脂的影响。方法对 62例围绝经期、绝经期妇女以年龄分为老年前期及老年期两组,采用结合雌激素 (CE)治疗 4周期,围绝经期症状以 Kupperman评分进行评估。用药前后分别测定促卵泡激素 (FSH)、雌二醇 (E2)、总胆固醇 (TC)、甘油三酯 (TG)、高密度脂蛋白 (HDL C)、低密度脂蛋白 (LDL C)。结果两组治疗后 Kupperman评分显著下降;两组 FSH显著下降, E2显著上升; TC显著下降, HDL- C显著上升, LDL- C/HDL- C显著下降,两组比较疗效无显著差异。结论结合雌激素对老年前期及老年期患者均可有效缓解围绝经期症状,改善血脂构成。 Objective To determine the effect of conjugated estrogen(CE) on perimenopause syndrome and serum lipoprotein in perimenopausal and postmenopausal women. Methods 62 perimenopausal and postmenopausal women divided into the presenium group and the elderly group were treated for 4 periods with CE.Perimenopause syndrome was evaluated by Kupperman score.Serum levels of FSH,E2 and Total Cholesterol (TC),Triglycerin (TG),high density lipoprotein (HDL C),low density lipoprotein (LDL C) were measured before and after treatment.Results Kupperman score of two groups decreased significantly.The serum level of E2 increased and reached effective level,while FSH decreased significantly.HDL C increased significantly,while TC and LDL C/HDL C decreased significantly.The results had no significantly difference between two groups.Conclusions CE is highly effective in relieving perimenopause syndrome and regulates the constitution of serum lipoprotein.
出处 《老年医学与保健》 CAS 2001年第1期43-46,共4页 Geriatrics & Health Care
关键词 结合雌激素 围绝经期 血脂 绝经期 激素替代治疗 Conjugated Estrogen Perimenopause syndrome Serum Lipoprotein
  • 相关文献

参考文献5

二级参考文献15

  • 1王抒,李健斋,赵淑华,唐蔚青,褚德发,李培瑛,满咏,李红霞.血清载脂蛋白参考值[J].中华医学检验杂志,1996,19(6):343-348. 被引量:30
  • 2吕文佩 郑淑蓉 杨欣.激素替代治疗对更年期症状的治疗作用[J].中华妇产科杂志,1997,32(10):563-563.
  • 3吴宜勇,中华内分泌代谢杂志,1990年,1期,56页
  • 4杨昌国,临床检验杂志,1995年,13卷,287页
  • 5刘秉文,脂蛋白与动脉粥样硬化,1995年
  • 6李健斋,中华老年医学杂志,1990年,9卷,200页
  • 7李健斋,中华医学杂志,1986年,66卷,531页
  • 8白文佩,中华妇产科杂志,1997年,32卷,563页
  • 9陶寿琪,中华心血管病杂志,1997年,25卷,234页
  • 10中华心血管病杂志编委会血脂异常防治对策专,中华心血管病杂志,1997年,25卷,169页

共引文献3171

同被引文献19

  • 1郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,1993.70.
  • 2丰有吉.妇产科学[M].北京:人民卫生出版社,2000.347.
  • 3CHOBANIAN A V, BAKRIS G L, BLACK H R Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report[J]. JAMA, 2003,289:2560-2572.
  • 4刘力生.2005中国高血压病防治指南[M].北京:人民卫生出版社,2007:1-8.
  • 5HARRAP S B. Where are all the blood-pressure genes?[J]. Lancet, 2003,361:2149-2151.
  • 6CAULFIELD M, MUNROE P, PEMBROKE J, et al. Genome-wide mapping of human loci for essential hypertension [J]. Lancet, 2003,361:2118-2123.
  • 7WALLANCE D C. Mitochondrial diseases in man and mouse[J]. Science, 1999, 283 : 1482-1488.
  • 8ANTHONY H V. Mitochondrial disease[J]. Lancet, 2006,368: 70-82.
  • 9MONAHAN K D. Effect of aging on baroreflex function in humans [J]. Am J Physiol Regul Integr Comp Physiol, 2007, 293:R3-R12.
  • 10SUN F, CUI J, GAVRAS H, et al. A novel class of tests for the detection of mitochondrial DNA-mutation involvement in diseases[J]. Am J Hum-Genet,2003, 72:1515-1526.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部